(Press-News.org) MIAMI, FLORIDA (EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET) – Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a first-of-its-kind, orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells.
They validated their targets in human prostate cancer biopsies, tested the new approach in human cancer cells and a mouse model of prostate cancer, showed that it is safe and effective in shrinking treatment-resistant cancers, and published results as the cover article in ACS Central Science, an American Chemical Society journal.
Although cisplatin is one of the most potent chemotherapy drugs in use against a variety of cancers, it has not been effective in treating prostate cancer. The Sylvester researchers’ compound – Platin-L – works in two ways, breaking down a process that malignant prostate cancer cells use to fuel their growth, and delivering cisplatin directly into treatment-resistant cancer cells.
“We believe Platin-L can circumvent these resistance mechanisms,” said Shanta Dhar, Ph.D., assistant director of Technology and Innovation at Sylvester Comprehensive Cancer Center, an associate professor of Biochemistry and Molecular Biology, a researcher, co-leader of Engineering Cancer Cures, and the study’s senior author.
Normal prostate gland cells use a biochemical reaction to turn glucose into energy, and in most types of cancers, this same process – glycolysis – supports proliferation, growth, and metastasis. But prostate cancer and some other cancers are different. As they advance, they switch from glycolysis and alter enzymes that enable them to derive energy through a process called fatty acid oxidation (FAO). The tumor cells use fat instead of sugar for energy.
Platin-L targets a key component of this process: CPT1A, a protein in mitochondria, which are organelles within cells that generate energy.
“We know that when this compound binds to CPT1A, it inhibits fat metabolism and is eventually transported to the mitochondria, where it damages mitochondrial DNA and helps overcome resistance,” Dhar said. “We are also making prostate cancer cells choose a less favorable metabolic pathway, which is insufficient to their needs, making it difficult for them to survive.”
In the study, researchers treated both patient prostate tumor samples and cisplatin-resistant animal models. Platin-L, which is called a “prodrug” because it only turns into an active drug when metabolized in the body, destroyed the cancer cells by robbing them of their energy source and dismantling both mitochondrial and nuclear DNA.
Platin-L was encapsulated in nanoparticles targeting a protein called prostate-specific membrane antigen (PSMA), which is highly expressed in prostate tumors. This design allows the drug to be taken orally, and because its effects are largely contained within prostate cancer cells, side effects in other parts of the body are limited. In mouse models, tumors in animals treated with Platin-L shrank – unlike those untreated or treated with cisplatin alone – and the treated mice had steady body weight, increased survival rates, and little evidence of the peripheral neuropathy that often results from cisplatin treatment.
The researchers believe other nanoparticles could be engineered to target other cancers; in fact, the nanoparticles repurposed for prostate cancer in this study were initially developed in response to South Florida’s Zika virus outbreak in 2016.
“We made a dual-targeted nanoparticle,” Dhar said. “The first targeting is needed to get it through the gut barrier, and the second targeting takes it to the prostate. The beauty is, now we can deliver a cisplatin-based chemotherapeutic orally, which is usually never done. And by targeting the prostate, we can reduce kidney and liver toxicity and the risk of peripheral neuropathy.”
Dhar and colleagues say the results of this preclinical work appear promising for future clinical trials and development.
“The impact of this current targeted metabolic modulation of the tumor microenvironment for advanced prostate cancer extends beyond this cancer type,” the authors wrote. “The reported mechanistic investigations will allow us to find the clues to make this platform more general to be used for cancers where these cellular pathways can be altered.”
Funding: This work was supported, in whole or in part, by the Sylvester Comprehensive Cancer Center and a Bankhead-Coley Grant (8BC10) from the Florida Department of Health (to S.D.). We also acknowledge National Cancer Institute-funded Sylvester Cancer Center support grant 1P30CA240139.
Authors: Dhar is senior author. Akil Kalathil, Subham Guin, Akash Ashokan, and Uttara Basu are first authors. Co-authors include Bapurao Surnar, Katiana Delma, Leonor Lima, Oleksandr Kryvenko. All are affiliated with the University of Miami Miller School of Medicine.
Potential conflicts: The authors declare no competing financial interest.
Article: ACS Central Science: New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance
DOI: https://doi.org/10.1021/acscentsci.3c00286
# # #
MEDIA CONTACT:
Sandy Van
sandy.van@miami.edu
808.206.4576
EMBARGOED UNTIL JULY 12, 2023, AT 8AM ET
For an advance, EMBARGOED copy of the study, please email sandy.van@miami.edu. Thank you.
END
Monika Wieland Shields, Director of the Orca Behavior Institute, has observed orcas in the Salish Sea, a marginal sea of the Pacific Ocean located in the Canadian province of British Columbia and the U.S. state of Washington, since 2000. She has recently published an article in the peer-reviewed Open Access journal PeerJ Life & Environment that provides crucial insights into the changing habitat usage of the critically endangered Southern Resident killer whales (Orcinus orca), shedding light on historic trends and the current status of the population in the Salish Sea. ...
COLUMBUS, Ohio - A new $3.9 million grant from the U.S. Food and Drug Administration (FDA) will allow researchers with the Center for Tobacco Research at The Ohio State University Comprehensive Cancer Center to evaluate effects of e-cigarette flavors on the smoking behaviors of current adult smokers.
The study, co-led by Theodore Wagener, PhD, director of Ohio State’s Center for Tobacco Research, and Tracy Smith, PhD, of the Medical University of South Carolina (MUSC) Hollings Cancer Center, will be the first ...
In a major Swedish study, researchers have discovered a link between the levels of certain bacteria living in the gut and coronary atherosclerotic plaques. Such atherosclerotic plaques, which are formed by the build-up of fatty and cholesterol deposits, constitute a major cause of heart attacks. The study was led by researchers at Uppsala and Lund University and the findings have now been published in the scientific journal Circulation.
The new study was based on analyses of gut bacteria and cardiac imaging among 8,973 participants aged 50 to 65 from Uppsala and Malmö without previously known heart disease. They were all ...
Findings challenge the traditional view that antimicrobial resistance (AMR) emerges from pathogens that acquire new mutations
Samples from ICU patients suggest that instead, highly diverse pathogen communities harbour pre-existing resistant genotypes
The results suggest that interventions aimed at limiting the spread of bacteria between patients may provide a powerful approach to combat AMR.
A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections. The findings, published today in the journal ...
Routine blood pressure readings recorded in the first half of pregnancy can be divided into 6 distinct patterns that can effectively stratify patients by their risk of developing preeclampsia and gestational hypertension later in pregnancy, Kaiser Permanente researchers found.
The study, published July 12 in the Journal of the American Heart Association, showed that 6 pregnancy blood pressure trajectories seen within the first 20 weeks of pregnancy along with clinical, social, and behavioral risk factors can accurately predict and stratify risk of preeclampsia and gestational hypertension in low- to moderate-risk patients. ...
Gulf War Illness (GWI) is a chronic multisymptom health condition affecting one-third of all veterans who served in the 1991 Gulf War, most of whom remain afflicted more than 30 years later. Common symptoms include fatigue, headaches, muscle aches, joint pain, diarrhea, insomnia and cognitive impairment.
The condition is believed to have been triggered by veterans’ exposure to environmental toxins. However, its exact mechanism in the body continues to be debated, making it difficult to diagnose and treat. The prevailing ...
An overdosed gene on chromosome 21 causes people with Down’s Syndrome to age faster than the general population.
The molecular processes responsible for natural ageing of cells are poorly understood. Studying conditions in humans where ageing is accelerated due to genetic causes presents opportunities to learn about the mechanisms that control ageing and devise strategies to slow down the ageing process.
Adults who have Down’s Syndrome (DS) show earlier signs of ageing-related conditions: reduction in tissue regenerative capacity, alopecia, dry skin, ...
Scientists have discovered the traces of the world’s oldest known glaciers, dating from 2.9 billion years ago, in rocks sitting under the world’s largest gold deposits in South Africa. This suggests the presence of continental ice caps at that time and that either the area was closer to the poles, or that parts of the Earth may have been frozen in a previously unknown “snowball Earth” period of extreme cold weather. This work is presented for the first time at the Goldschmidt geochemistry conference in Lyon, after recent peer-reviewed ...
A new paper in Genome Biology and Evolution, published by Oxford University Press, finds that the annulated sea snake, a species of venomous snake found in ocean waters around Australia and Asia, appears to have evolved to see an extended palette of colors after its ancestors lost that ability in response to changing environments.
Color vision in animals is primarily determined by genes called visual opsins. While there have been multiple losses of opsin genes during the evolution of tetrapods (the group including amphibians, reptiles, and mammals), the emergence of new opsin genes is extremely ...
A research group from Nagoya University has accurately simulated air turbulence occurring on clear days around Tokyo using Japan’s fastest supercomputer. They then compared their findings with flight data to create a more accurate predictive model. The research was reported in the journal Geophysical Research Letters.
Although air turbulence is usually associated with bad weather, an airplane cabin can shake violently even on a sunny and cloudless day. Known as clear air turbulence (CAT), these turbulent ...
